American Bitcoin Corp.: peers
American Bitcoin Corp. beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.
Phreesia, Inc.: the market cap on file is more than 60 days old or a last known value (no market-data feed for its exchange yet), so its valuation multiples and yields are shown but not ranked.
Side by side#
Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.
| Measure | American Bitcoin Corp.base ABTC · 🇺🇸 US Percentile in Healthcare Percentile in USA | Phreesia, Inc. PHR · 🇺🇸 US Percentile in Healthcare Percentile in USA | Evolent Health, Inc. EVH · 🇺🇸 US Percentile in Healthcare Percentile in USA | HealthStream, Inc. HSTM · 🇺🇸 US Percentile in Healthcare Percentile in USA | GoodRx GDRX · 🇺🇸 US Percentile in Healthcare Percentile in USA | American Well Corporation AMWL · 🇺🇸 US Percentile in Healthcare Percentile in USA | Teladoc Health, Inc. TDOC · 🇺🇸 US Percentile in Healthcare Percentile in USA | Omnicell, Inc. OMCL · 🇺🇸 US Percentile in Healthcare Percentile in USA | Group median |
|---|---|---|---|---|---|---|---|---|---|
| Size | |||||||||
| Market cap (Better neither way: ranked highest first) | $546 MOct 30, 2026 · Market data6th of 8 | $759 MAug 1, 2026 · Market data5th of 8 | $383 MOct 2, 2026 · Market data7th of 8 | $1.0 BOct 14, 2026 · Market data4th of 8 | $1.2 BOct 14, 2026 · Market data3rd of 8 | $233 MOct 27, 2026 · Market data8th of 8 | $1.6 BOct 30, 2026 · Market data2nd of 8 | $1.7 BOct 27, 2026 · Market data1st of 8 | $896 M8 ranked |
| Revenue (Better neither way: ranked highest first) | $185 MFY2025 · SEC8th of 8 | $481 MFY2025 · SEC5th of 8 | $1.9 BFY2025 · SEC2nd of 8 | $304 MFY2025 · SEC6th of 8 | $797 MFY2025 · SEC4th of 8 | $249 MFY2025 · SEC7th of 8 | $2.5 BFY2025 · SEC1st of 8 | $1.2 BFY2025 · SEC3rd of 8 | $639 M8 ranked |
| Net income (Higher is better) | $-153 MFY2025 · SEC6th of 8 | $2 MFY2025 · SEC3rd of 8 | $-535 MFY2025 · SEC8th of 8 | $18 MFY2025 · SEC2nd of 8 | $30 MFY2025 · SEC1st of 8 | $-96 MFY2025 · SEC5th of 8 | $-200 MFY2025 · SEC7th of 8 | $2 MFY2025 · SEC4th of 8 | $-47 M8 ranked |
| Employees (Better neither way: ranked highest first) | —— | 827As on January 2021 · Profile5th of 6 | 3,500As on December 2021 · Profile3rd of 6 | —— | 954As on 2022 · Profile4th of 6 | 527As on 2021 · Profile6th of 6 | 5,600As on 2022 · Profile1st of 6 | 3,800As on December 2021 · Profile2nd of 6 | 2,2276 ranked |
| Growth | |||||||||
| Market cap change, 30 days (Higher is better) | —— | —— | —— | —— | —— | +0.5%30 days to Oct 27, 2026 · Market dataonly one with it | —— | —— | +0.5%— |
| Revenue growth (Higher is better) | +158.8%FY2025 · SEC1st of 895th97th | +14.5%FY2025 · SEC2nd of 859th70th | -26.6%FY2025 · SEC8th of 89th4th | +4.3%FY2025 · SEC4th of 835th43rd | +0.6%FY2025 · SEC5th of 827th31st | -2.0%FY2025 · SEC7th of 821st24th | -1.5%FY2025 · SEC6th of 822nd25th | +6.5%FY2025 · SEC3rd of 841st50th | +2.4%8 ranked |
| Revenue growth, 3 years a year (Higher is better) | +160.6%FY2025 · SEC1st of 898th99th | +19.6%FY2025 · SEC2nd of 872nd85th | +11.5%FY2025 · SEC3rd of 857th73rd | +4.5%FY2025 · SEC4th of 840th51st | +1.3%FY2025 · SEC6th of 830th37th | -3.5%FY2025 · SEC8th of 819th22nd | +1.7%FY2025 · SEC5th of 831st39th | -2.9%FY2025 · SEC7th of 819th23rd | +3.1%8 ranked |
| Earnings per share growth (Higher is better) | ———— | ———— | ———— | -7.6%FY2025 · SEC2nd of 329th30th | +125.0%FY2025 · SEC1st of 389th91st | ———— | ———— | -85.2%FY2025 · SEC3rd of 31st1st | -7.6%3 ranked |
| Margins and returns | |||||||||
| Gross margin (Higher is better) | 50.3%FY2025 · SEC1st of 336th64th | ———— | 21.3%FY2025 · SEC3rd of 310th22nd | ———— | ———— | ———— | ———— | 42.5%FY2025 · SEC2nd of 326th54th | 42.5%3 ranked |
| Operating margin (Higher is better) | -123.1%FY2025 · SEC8th of 821st9th | -1.4%FY2025 · SEC4th of 856th38th | -21.9%FY2025 · SEC6th of 840th21st | 6.7%FY2025 · SEC2nd of 867th60th | 11.0%FY2025 · SEC1st of 875th70th | -42.2%FY2025 · SEC7th of 833rd16th | -10.4%FY2025 · SEC5th of 848th27th | 0.4%FY2025 · SEC3rd of 858th41st | -5.9%8 ranked |
| Net margin (Higher is better) | -82.7%FY2025 · SEC8th of 825th11th | 0.5%FY2025 · SEC3rd of 861st44th | -28.5%FY2025 · SEC6th of 839th19th | 6.0%FY2025 · SEC1st of 871st64th | 3.8%FY2025 · SEC2nd of 868th57th | -38.4%FY2025 · SEC7th of 834th16th | -7.9%FY2025 · SEC5th of 850th29th | 0.2%FY2025 · SEC4th of 861st43rd | -3.9%8 ranked |
| Free cash flow margin (Higher is better) | ———— | 14.1%FY2025 · SEC3rd of 679th79th | ———— | 19.6%FY2025 · SEC2nd of 687th87th | 20.6%FY2025 · SEC1st of 689th89th | -26.5%FY2025 · SEC6th of 634th15th | 11.3%FY2025 · SEC4th of 674th73rd | 7.3%FY2025 · SEC5th of 667th61st | 12.7%6 ranked |
| Return on equity (Higher is better) | -18.2%FY2025 · SEC6th of 861st29th | 0.8%FY2025 · SEC3rd of 873rd43rd | -75.5%FY2025 · SEC8th of 832nd14th | 5.1%FY2025 · SEC1st of 876th51st | 4.5%FY2025 · SEC2nd of 876th50th | -35.4%FY2025 · SEC7th of 851st22nd | -13.9%FY2025 · SEC5th of 864th31st | 0.2%FY2025 · SEC4th of 873rd42nd | -6.9%8 ranked |
| Return on invested capital (Higher is better) | ———— | ———— | ———— | ———— | 5.8%FY2025 · SEConly one with it22nd21st | ———— | ———— | ———— | 5.8%— |
| Valuation | |||||||||
| P/E ratio (Better neither way: ranked highest first) | ———— | 72.6׆price Aug 1, 2026 · Market datanot ranked: old priceold priceold price | ———— | 50.5×price Oct 14, 2026 · Market data2nd of 371st87th | 72.4×price Oct 14, 2026 · Market data1st of 382nd92nd | ———— | ———— | 38.1×price Oct 27, 2026 · Market data3rd of 358th80th | 50.5×3 ranked |
| Price to sales (Better neither way: ranked highest first) | 2.0×price Oct 30, 2026 · Market data2nd of 733rd48th | 1.5׆price Aug 1, 2026 · Market datanot ranked: old priceold priceold price | 0.2×price Oct 2, 2026 · Market data7th of 71st4th | 3.1×price Oct 14, 2026 · Market data1st of 745th62nd | 1.5×price Oct 14, 2026 · Market data3rd of 724th40th | 1.1×price Oct 27, 2026 · Market data5th of 719th32nd | 0.6×price Oct 30, 2026 · Market data6th of 711th20th | 1.4×price Oct 27, 2026 · Market data4th of 723rd37th | 1.4×7 ranked |
| Price to book (Better neither way: ranked highest first) | 0.8×price Oct 30, 2026 · Market data7th of 716th15th | 2.3׆price Aug 1, 2026 · Market datanot ranked: old priceold priceold price | 0.9×price Oct 2, 2026 · Market data6th of 718th18th | 2.9×price Oct 14, 2026 · Market data1st of 749th61st | 1.9×price Oct 14, 2026 · Market data2nd of 737th46th | 1.0×price Oct 27, 2026 · Market data5th of 719th20th | 1.1×price Oct 30, 2026 · Market data4th of 721st25th | 1.4×price Oct 27, 2026 · Market data3rd of 727th33rd | 1.1×7 ranked |
| Free cash flow yield (Higher is better) | -11.1%price Oct 30, 2026 · Market data5th of 741st20th | 8.9%†price Aug 1, 2026 · Market datanot ranked: old priceold priceold price | -20.4%price Oct 2, 2026 · Market data6th of 733rd15th | 5.8%price Oct 14, 2026 · Market data3rd of 789th70th | 14.0%price Oct 14, 2026 · Market data2nd of 796th92nd | -28.3%price Oct 27, 2026 · Market data7th of 727th12th | 17.9%price Oct 30, 2026 · Market data1st of 798th95th | 5.1%price Oct 27, 2026 · Market data4th of 788th67th | 5.1%7 ranked |
| Financial strength | |||||||||
| Debt to equity (Lower is better) | ———— | 0.0×FY2025 · SEC1st of 310th7th | 2.3×FY2025 · SEC3rd of 390th88th | ———— | 0.8×FY2025 · SEC2nd of 370th61st | ———— | ———— | ———— | 0.8×3 ranked |
| Net debt to EBITDA (Lower is better) | ———— | -2.9×FY2025 · SEC1st of 26th3rd | ———— | ———— | 1.4×FY2025 · SEC2nd of 246th40th | ———— | ———— | ———— | -0.8×2 ranked |
| Piotroski F-score (Higher is better) | —— | —— | 5 of 9FY2025 · SEConly one with it | —— | —— | —— | —— | —— | 5.0 of 9— |
| Scorecard | |||||||||
| Scorecard (Higher is better) | 7 of 20FY2025 · Scorecard7th of 8 | 12 of 17FY2025 · Scorecard1st of 8 | 8 of 22FY2025 · Scorecard6th of 8 | 15 of 25FY2025 · Scorecard3rd of 8 | 16 of 26FY2025 · Scorecard2nd of 8 | 5 of 20FY2025 · Scorecard8th of 8 | 8 of 20FY2025 · Scorecard5th of 8 | 13 of 23FY2025 · Scorecard4th of 8 | 48% passed8 ranked |
| Valuation checks (Higher is better) | 1 of 5FY2025 · Scorecard6th of 7 | —— | 2 of 5FY2025 · Scorecard4th of 7 | 1 of 6FY2025 · Scorecard7th of 7 | 3 of 6FY2025 · Scorecard2nd of 7 | 2 of 5FY2025 · Scorecard4th of 7 | 4 of 6FY2025 · Scorecard1st of 7 | 3 of 6FY2025 · Scorecard2nd of 7 | 40% passed7 ranked |
| Growth checks (Higher is better) | 4 of 6FY2025 · Scorecard2nd of 8 | 6 of 6FY2025 · Scorecard1st of 8 | 2 of 6FY2025 · Scorecard5th of 8 | 3 of 6FY2025 · Scorecard4th of 8 | 4 of 6FY2025 · Scorecard2nd of 8 | 1 of 6FY2025 · Scorecard6th of 8 | 1 of 6FY2025 · Scorecard6th of 8 | 1 of 6FY2025 · Scorecard6th of 8 | 42% passed8 ranked |
| Profitability checks (Higher is better) | 1 of 5FY2025 · Scorecard6th of 8 | 3 of 5FY2025 · Scorecard2nd of 8 | 0 of 5FY2025 · Scorecard8th of 8 | 4 of 5FY2025 · Scorecard1st of 8 | 3 of 6FY2025 · Scorecard4th of 8 | 1 of 5FY2025 · Scorecard6th of 8 | 1 of 4FY2025 · Scorecard5th of 8 | 3 of 5FY2025 · Scorecard2nd of 8 | 38% passed8 ranked |
| Financial health checks (Higher is better) | 0 of 3FY2025 · Scorecard8th of 8 | 3 of 5FY2025 · Scorecard5th of 8 | 2 of 4FY2025 · Scorecard6th of 8 | 2 of 3FY2025 · Scorecard3rd of 8 | 4 of 5FY2025 · Scorecard2nd of 8 | 1 of 3FY2025 · Scorecard7th of 8 | 2 of 3FY2025 · Scorecard3rd of 8 | 3 of 3FY2025 · Scorecard1st of 8 | 63% passed8 ranked |
| Shareholder returns checks (Higher is better) | 1 of 1FY2025 · Scorecard1st of 8 | 0 of 1FY2025 · Scorecard6th of 8 | 2 of 2FY2025 · Scorecard1st of 8 | 5 of 5FY2025 · Scorecard1st of 8 | 2 of 3FY2025 · Scorecard5th of 8 | 0 of 1FY2025 · Scorecard6th of 8 | 0 of 1FY2025 · Scorecard6th of 8 | 3 of 3FY2025 · Scorecard1st of 8 | 83% passed8 ranked |
| Ownership | |||||||||
| Held by institutions (Better neither way: ranked highest first) | 7.5%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in8th of 8 | 92.9%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 8 | 92.6%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 8 | 73.5%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in5th of 8 | 35.0%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in7th of 8 | 47.0%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in6th of 8 | 87.1%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 8 | 104.6%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 8 | 80.3%8 ranked |
| Institutions holding (Better neither way: ranked highest first) | 912026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in7th of 8 | 2302026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 8 | 1932026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in5th of 8 | 2162026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 8 | 1812026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in6th of 8 | 672026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in8th of 8 | 3242026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 8 | 3042026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 8 | 2058 ranked |
| Institutional holding, change over the quarter (Better neither way: ranked highest first) | —— | -2.2 pp2026-Q2 against 2026-Q1 · 13F5th of 5 | +1.1 pp2026-Q2 against 2026-Q1 · 13F4th of 5 | +4.3 pp2026-Q2 against 2026-Q1 · 13F2nd of 5 | —— | —— | +5.1 pp2026-Q2 against 2026-Q1 · 13F1st of 5 | +3.0 pp2026-Q2 against 2026-Q1 · 13F3rd of 5 | +3.0 pp5 ranked |
| Dividends | |||||||||
| Dividend yield (Higher is better) | ———— | ———— | ———— | 0.4%FY2025 · SEConly one with it25th11th | ———— | ———— | ———— | ———— | 0.4%— |
| Shareholder yield (Higher is better) | ———— | ———— | 10.4%FY2025 · SEC2nd of 492nd89th | 3.3%FY2025 · SEC4th of 462nd51st | 18.4%FY2025 · SEC1st of 497th96th | ———— | ———— | 4.6%FY2025 · SEC3rd of 473rd64th | 7.5%4 ranked |
| Dividend payout (Better neither way: ranked highest first) | ———— | ———— | ———— | 20.2%FY2025 · SEConly one with it37th22nd | ———— | ———— | ———— | ———— | 20.2%— |
| Dividend per share (Better neither way: ranked highest first) | —— | —— | —— | $0.12FY2025 · SEConly one with it | —— | —— | —— | —— | $0.12— |
Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).
† The market cap behind this figure is more than 60 days old (no market-data feed for that exchange yet): it is shown but not ranked or given a percentile.
Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = American Bitcoin Corp.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Phreesia, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Evolent Health, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; HealthStream, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; GoodRx: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; American Well Corporation: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Teladoc Health, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Omnicell, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover.
Where each stands in its sector and country: Operating margin#
The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.
| Company | Operating margin | In its sector | In its country |
|---|---|---|---|
| American Bitcoin Corp. | -123.1%FY2025 | 21st percentile in Healthcaremedian -7.8%, 678 companies | 9th percentile in USAmedian 3.4%, 2,607 companies |
| Phreesia, Inc. | -1.4%FY2025 | 56th percentile in Healthcaremedian -7.8%, 678 companies | 38th percentile in USAmedian 3.4%, 2,607 companies |
| Evolent Health, Inc. | -21.9%FY2025 | 40th percentile in Healthcaremedian -7.8%, 678 companies | 21st percentile in USAmedian 3.4%, 2,607 companies |
| HealthStream, Inc. | 6.7%FY2025 | 67th percentile in Healthcaremedian -7.8%, 678 companies | 60th percentile in USAmedian 3.4%, 2,607 companies |
| GoodRx | 11.0%FY2025 | 75th percentile in Healthcaremedian -7.8%, 678 companies | 70th percentile in USAmedian 3.4%, 2,607 companies |
| American Well Corporation | -42.2%FY2025 | 33rd percentile in Healthcaremedian -7.8%, 678 companies | 16th percentile in USAmedian 3.4%, 2,607 companies |
| Teladoc Health, Inc. | -10.4%FY2025 | 48th percentile in Healthcaremedian -7.8%, 678 companies | 27th percentile in USAmedian 3.4%, 2,607 companies |
| Omnicell, Inc. | 0.4%FY2025 | 58th percentile in Healthcaremedian -7.8%, 678 companies | 41st percentile in USAmedian 3.4%, 2,607 companies |
Revenue by fiscal year, and the rank in the group#
Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).
Revenue
Rank in the group
| Fiscal year | American Bitcoin Corp. | Phreesia, Inc. | Evolent Health, Inc. | HealthStream, Inc. | GoodRx | American Well Corporation | Teladoc Health, Inc. | Omnicell, Inc. |
|---|---|---|---|---|---|---|---|---|
| 2025 | $185 MSEC8th | $481 MSEC5th | $1.9 BSEC2nd | $304 MSEC6th | $797 MSEC4th | $249 MSEC7th | $2.5 BSEC1st | $1.2 BSEC3rd |
| 2024 | $72 MSEC8th | $420 MSEC5th | $2.6 BSEC2nd | $292 MSEC6th | $792 MSEC4th | $254 MSEC7th | $2.6 BSEC1st | $1.1 BSEC3rd |
| 2023 | $65 MSEC8th | $356 MSEC5th | $2.0 BSEC2nd | $279 MSEC6th | $750 MSEC4th | $259 MSEC7th | $2.6 BSEC1st | $1.1 BSEC3rd |
| 2022 | $10 MSEC8th | $281 MSEC5th | $1.4 BSEC2nd | $267 MSEC7th | $767 MSEC4th | $277 MSEC6th | $2.4 BSEC1st | $1.3 BSEC3rd |
| 2021 | $18 MSEC8th | $213 MSEC7th | $908 MSEC3rd | $257 MSEC5th | $745 MSEC4th | $253 MSEC6th | $2.0 BSEC1st | $1.1 BSEC2nd |
| 2020 | $13 MSEC8th | $149 MSEC7th | $925 MSEC2nd | $245 MSEC6th | $551 MSEC4th | $245 MSEC5th | $1.1 BSEC1st | $892 MSEC3rd |
| 2019 | $11 MSEC8th | $125 MSEC7th | $687 MSEC2nd | $254 MSEC5th | $388 MSEC4th | $149 MSEC6th | $553 MSEC3rd | $897 MSEC1st |
| 2018 | $10 MSEC8th | $100 MSEC7th | $627 MSEC2nd | $232 MSEC5th | $250 MSEC4th | $114 MSEC6th | $418 MSEC3rd | $787 MSEC1st |
| 2017 | — | $80 MSEC5th | $435 MSEC2nd | $215 MSEC4th | — | — | $233 MSEC3rd | $713 MSEC1st |
| 2016 | — | — | $254 MSEC2nd | $192 MSEC3rd | — | — | $123 MSEC4th | $696 MSEC1st |
| 2015 | — | — | $97 MSEC3rd | $209 MSEC2nd | — | — | $77 MSEC4th | $485 MSEC1st |
| 2014 | — | — | — | $171 MSEC2nd | — | — | $44 MSEC3rd | $441 MSEC1st |
Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.
Suggested peers of American Bitcoin Corp.#
Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.
- Phreesia, Inc.PHR · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $759 M market cap against $546 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $759 M (Aug 1, 2026) · revenue $481 M (year to January 2026)98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)In the group
- Evolent Health, Inc.EVH · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $383 M market cap against $546 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $383 M (Oct 2, 2026) · revenue $1.9 B (year to December 2025)98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)In the group
- HealthStream, Inc.HSTM · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $1.0 B market cap against $546 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $1.0 B (Oct 14, 2026) · revenue $304 M (year to December 2025)96 of 100 (industry or sector 50 + size 26 + country 15 + figures on file 5)In the group
- GoodRxGDRX · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $1.2 B market cap against $546 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $1.2 B (Oct 14, 2026) · revenue $797 M (year to December 2025)95 of 100 (industry or sector 50 + size 25 + country 15 + figures on file 5)In the group
- American Well CorporationAMWL · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $233 M market cap against $546 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $233 M (Oct 27, 2026) · revenue $249 M (year to December 2025)94 of 100 (industry or sector 50 + size 25 + country 15 + figures on file 5)In the group
- Teladoc Health, Inc.TDOC · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $1.6 B market cap against $546 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $1.6 B (Oct 30, 2026) · revenue $2.5 B (year to December 2025)93 of 100 (industry or sector 50 + size 23 + country 15 + figures on file 5)In the group
- Omnicell, Inc.OMCL · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $1.7 B market cap against $546 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $1.7 B (Oct 27, 2026) · revenue $1.2 B (year to December 2025)93 of 100 (industry or sector 50 + size 23 + country 15 + figures on file 5)In the group
- OptimizeRx CorporationOPRX · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $165 M market cap against $546 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $165 M (Oct 20, 2026) · revenue $109 M (year to December 2025)92 of 100 (industry or sector 50 + size 22 + country 15 + figures on file 5)+ Add
- Schrödinger, Inc.SDGR · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $1.9 B market cap against $546 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $1.9 B (Oct 15, 2026) · revenue $256 M (year to December 2025)92 of 100 (industry or sector 50 + size 22 + country 15 + figures on file 5)+ Add
- Progyny, Inc.PGNY · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $2.1 B market cap against $546 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $2.1 B (Oct 21, 2026) · revenue $1.3 B (year to December 2025)91 of 100 (industry or sector 50 + size 21 + country 15 + figures on file 5)+ Add
- Health Catalyst, Inc.HCAT · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $139 M market cap against $546 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $139 M (Aug 1, 2026) · revenue $311 M (year to December 2025)91 of 100 (industry or sector 50 + size 21 + country 15 + figures on file 5)+ Add
- Allscripts Healthcare SolutionsMDRX · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $1.2 B market cap against $546 M · Same country: USAMarket cap $1.2 B (last known, Jan 5, 2024) · revenue $1.5 B (year to December 2021)90 of 100 (industry or sector 50 + size 25 + country 15)+ Add
Any figure over the years, other peers or a saved group: open this group in the peer workspace.